EDIT vs SNA · rev $32.3M vs P/E 17, rev $5.11B
Editas Medicine Inc (EDIT) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported SNA revenue for 2024-12-28 was $5.11B. Net income was $1.07B. Revenue was up 0.0% from 2023-12-30 to 2024-12-28. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
EDIT currently screens at market cap $375.2M. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the EDIT and SNA stock pages for the full models.
Not investment advice.